Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and CGF in Mandibular Third Molar Surgery
NCT07320170Completed
- Sponsor
- Recep Tayyip Erdoğan University
- Start
- May 2024
- Primary completion
- May 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs, Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised trial of concentrated growth factor and platelet-rich plasma in impacted third molar (I3M) (3 arms), sponsored by Recep Tayyip Erdoğan University. Primary endpoint: Postoperative Pain assessed by Visual Analog Scale at 7 days. Started May 2024; status: completed.
02
Drugs
concentrated growth factorplatelet-rich plasma
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT07320170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07320170.